Overcoming Obesity 2023 - Framework for Individualizing Anti-Obesity Medication Therapy (Recorded) PB24
Selecting the correct on label or off label medication to treat obesity can be confusing. The acronym RXAOM provides a framework for individualizing the selection process. RXAOM stands for Reimbursement/cost, eXcluded, Additional reasons, Off-label option, Medication selection - shared decision. This presentation will use case studies from the presenters obesity practice to demonstrate using this process and making individualized selections.
CME/CE Expiration Date: 10/29/26
*The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.
- Evaluate evidence-based guidelines for pharmacologic management of chronic disease of obesity
- Identify available pharmacotherapeutics both on and off label that can be utilized to support treatment of chronic disease of obesity.
- Utilize the RXAOM process to make individualized medication selection through case studies.
Angela K. Golden, DNP, FNP-C, FAANP, FOMA
This session is approved by the American Association of Nurse Practitioners® for 1.0 pharmacology contact hour(s).
- 1.00 AMA PRA Category 1 Credit™The Obesity Medicine Association (OMA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Obesity Medicine Association designates this Enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the commensurate amount with the extent of their participation in the activity.